{"id":416,"date":"2024-08-07T11:53:43","date_gmt":"2024-08-07T16:53:43","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/cio\/?page_id=416"},"modified":"2026-10-02T14:14:59","modified_gmt":"2026-10-02T19:14:59","slug":"research","status":"publish","type":"page","link":"https:\/\/wp.uthscsa.edu\/cio\/research\/","title":{"rendered":"Research"},"content":{"rendered":"

[vc_row][vc_column width=”2\/3″][vc_column_text]<\/p>\n

Research Objectives<\/h2>\n

Our long-term goal is to pave the way to clinical innovations that <\/span>leverage<\/span> cancer genetics to improve <\/span><\/span>c<\/span>ancer <\/span>p<\/span>revention<\/span><\/span>.<\/span> To achieve <\/span>this,<\/span>\u00a0we<\/span> take a collaborative multidisciplinary approach to <\/span>advancing our understanding <\/span>of <\/span>the<\/span> genetic<\/span> component<\/span> of cancer risk<\/span> and its associations with<\/span> development and outcomes:<\/span><\/span>\u00a0<\/span>[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/2″]\n \"\"\n

Dissecting Mechanisms of DNA Damage Repair<\/h3><\/div>\n <\/a>\n \"\"\n

Identifying Genetic Variants Associated with Cancer Risk<\/h3><\/div>\n <\/a>[\/vc_column_inner][vc_column_inner width=”1\/2″]\n \"\"\n

Development of Novel Cancer Prevention\/Treatment Strategies<\/h3><\/div>\n <\/a>\n \"\"\n

Which Immune Elements Constitute a Microenvironment Permissive for Tumorigenesis?<\/h3><\/div>\n <\/a>[\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″]